NI Science Festival, in conjunction with Linen Biennale recently rolled out the virtual red carpet to premier Dr Anthony O’Kane’s ‘Translating Linen.’
Fusion Antibodies is delighted to be recognised as a Platinum Level Innovator in the Innovate NI Innovation Accreditation programme from the Department for the Economy.
Fusion Antibodies and Queen’s University Belfast Receive £453,000 grant from Invest Northern Ireland to Boost Research and Development for COVID-19 Antibodies
Dr Richard Buick, CTO of Fusion Antibodies explains what he believes to be the top criteria to consider when selecting a humanization outsourcing partner
Fusion Antibodies are celebrating their 200th Antibody Humanization project, cementing our place as a leading CRO in antibody engineering services.
Fusion Antibodies have leveraged their antigen expertise to create multiple antigens to be used against the COVID-19 pandemic.
Dr Leona McGirr of Fusion Antibodies has received a top honour at the annual celebration of the most outstanding Knowledge Transfer Partnership (KTP) Projects.
The most effective medicines in the world are of limited value if they can’t be produced in bulk, and at a reasonable cost. Therapeutic antibodies take years to develop. Without good oversight, each stage of development risks operating in a vacuum…
As part of our efforts to combat the Covid-19 pandemic, We have designed and expressed a panel of unique recombinant protein antigens to assist in the search for a neutralising therapeutic antibody against SARS-CoV 2.
Fusion Antibodies have named BioTickle as their exclusive distributor in India to provide access to proprietary antibody discovery, engineering and cell line development technologies.
info@fusionantibodies.com
+44 (0)28 9043 2800
Investor and Media
+44 (0)20 7933 8780
fusion@walbrookpr.com
Fusion Antibodies PLC, Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast BT17 0QL